European Journal of Molecular & Clinical Medicine

Abstract

Indian drug market is flooded with more than 70000 drug formulations, the majority of which are proprietary multi-drug combinations. The prescribing and buying of drugs is an issue of unparalled peculiarity because the prescriber (the doctor) decides what to buy, but he is not the one who pays for the drug; the one who pays and benefits (the patient) has no say in what he/she busy. The low comes into the picture for the price control of only a limited number of drugs and formulations